Weinbohla, Germany

Christine Siegemund


Average Co-Inventor Count = 9.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1993-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christine Siegemund: Innovator in Cerebroprotective Compounds

Introduction

Christine Siegemund is a notable inventor based in Weinbohla, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have cerebroprotective effects. With a total of two patents to her name, her work is paving the way for advancements in treating cerebral functional disorders.

Latest Patents

Christine's latest patents include the invention of N-acyl-4-phenyl-pyrrolidin-2-ones and methods for preparing them. This invention is directed towards N-acetyl-4-phenyl-pyrrolidin-2-ones, which are recognized for their pronounced cerebroprotective effects in human medicine. These compounds can be utilized for the prophylaxis and treatment of cerebral functional disorders. The synthesis of these compounds involves reacting 4-phenyl-pyrrolidin-2-ones with a reactive derivative of a carboxylic acid or by cyclizing N-acylaminobutyric acid derivatives. Additionally, she has developed substituted 5-(phenoxyalkanoylamino)-uracil compounds, which are designed for pharmaceutical compositions aimed at treating cerebrovascular, neuronal-degenerative, and senility-induced disorders associated with learning, memory, and cognitive dysfunctions.

Career Highlights

Christine Siegemund is currently associated with Arzneimittelwerk Dresden GmbH, where she continues her innovative work in pharmaceutical development. Her research focuses on creating effective treatments for cognitive disorders, showcasing her commitment to improving human health through scientific advancements.

Collaborations

Christine collaborates with esteemed colleagues such as Angelika Rostock and Dieter Lohmann. Their combined expertise contributes to the success of their research and the development of new therapeutic solutions.

Conclusion

Christine Siegemund's contributions to the field of pharmaceuticals highlight her role as an innovator in developing cerebroprotective compounds. Her work not only advances scientific knowledge but also holds the potential to significantly impact the treatment of cognitive disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…